MedTrace Logo

Preoperative Infusion of Levosimendan in Patients Undergoing Cardiac Surgery

NCT04635293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-11-19

No results posted yet for this study

Summary

The aim of this retrospective study will be to investigate the effect of the preoperative administration of levosimendan on the outcome of patients with compromised cardiac function undergoing cardiac surgery

Conditions

  • Cardiac Disease
  • Cardiac Failure
  • Cardiac Surgery
  • Inotropes
  • Ejection Fraction

Interventions

PROCEDURE

preoperative infusion of levosimendan

the study group will consist of patients who have received a continuous infusion of levosimendan 0.1 μg/kg/min for 24 hours before cardiac surgery

PROCEDURE

no preoperative infusion of levosimendan

the control group will consist of patients who proceeded to the cardiac operation without any infusion for 24 hours preoperatively

Sponsors & Collaborators

  • Aretaieion University Hospital

    lead OTHER

Principal Investigators

  • Kassiani Theodoraki, PhD, DESA · Aretaieion University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2020-11-09
Completion
2020-11-09

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04635293 on ClinicalTrials.gov